Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q1 2014 Earnings

27FebConfirmed

May 13

Q3 2013

Q4 2013

Q1 2014

-0.2

-0.18

-0.17

-0.15

Details

Expected EPS

N/A

Actual EPS

-0.19

Surprise EPS

-0.19

Surprise Percent

+∞%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.19 per share for Q1 2014.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.